Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Will End on February 17th

Zhengye Biotechnology’s (NASDAQ:ZYBT) quiet period will end on Monday, February 17th. Zhengye Biotechnology had issued 1,500,000 shares in its initial public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During Zhengye Biotechnology’s quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Zhengye Biotechnology Stock Up 14.1 %

NASDAQ:ZYBT opened at $4.94 on Friday. Zhengye Biotechnology has a 1 year low of $3.70 and a 1 year high of $6.10.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.